As of January 22, 2025, Adaptive Biotechnologies (ADPT) has a market cap of $1.18 billion USD. According to our data, Adaptive Biotechnologies is ranked No.4954 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.18 B |
33.61%
|
Dec 31, 2024 | $0.88 B |
22.35%
|
Dec 29, 2023 | $0.72 B |
-35.86%
|
Dec 30, 2022 | $1.13 B |
-72.77%
|
Dec 31, 2021 | $4.14 B |
-52.55%
|
Dec 31, 2020 | $8.73 B |
97.63%
|
Dec 31, 2019 | $4.42 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Illumina
ILMN
|
$22.26 B |
0.000 M
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.73 B |
0.006 M
|
USA
|
Bio-Rad Laboratories
BIO
|
$10.07 B |
1.804 B
|
USA
|
Guardant Health
GH
|
$5.83 B |
0.000 M
|
USA
|
Natera
NTRA
|
$22.70 B |
-0.001 M
|
USA
|
10x Genomics
TXG
|
$1.97 B |
0.229 B
|
USA
|
Pacific Biosciences
PACB
|
$0.52 B |
0.000 M
|
USA
|
NeoGenomics
NEO
|
$1.86 B |
0.000 M
|
USA
|
Personalis
PSNL
|
$0.48 B |
0.000 M
|
USA
|
Twist Bioscience
TWST
|
$3.12 B |
0.000 M
|
USA
|
Adaptive Biotechnologies
ADPT
|
$1.18 B |
0.000 M
|
USA
|
Fulgent Genetics
FLGT
|
$0.52 B |
0.000 M
|
USA
|
Veracyte
VCYT
|
$3.34 B |
-0.000 M
|
USA
|
Market Cap | = | ADPT Stock Price | * | ADPT Shares Outstanding |
= | $8.01 | * | 0.15 B | |
= | $1.18 B |